Caricamento...
Tumor-specific CD4(+) T cells maintain effector and memory tumor-specific CD8(+) T cells
Immunotherapies that augment antitumor T cells have had recent success for treating patients with cancer. Here we examined whether tumor-specific CD4(+) T cells enhance CD8(+) T-cell adoptive immunotherapy in a lymphopenic environment. Our model employed physiological doses of tyrosinase-related pro...
Salvato in:
| Pubblicato in: | Eur J Immunol |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BlackWell Publishing Ltd
2014
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4283993/ https://ncbi.nlm.nih.gov/pubmed/24114780 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/eji.201343718 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|